D-383-2014 Class II Terminated
FDA drug recall D-383-2014 was initiated by Sandoz Incorporated on Oct 22, 2013 and is designated Class II. Reason for recall: Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin The recall status is terminated (terminated Jul 10, 2014). Affected quantity: 12,521 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 1, 2014
- Initiation Date
- Oct 22, 2013
- Termination Date
- Jul 10, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12,521 bottles
Product description
Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz Inc., Princeton, NJ NDC 0781-2102-01
Reason for recall
Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin
Distribution pattern
Nationwide
Code information
Lots DE9898, DE9900, DE9903, DE9908, DE9911. Exp. 06/14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-383-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026